|
Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Raises approximately £228,081 through an underwritten open offer at an issue price of 0.2 pence per share. Valid acceptances were received from qualifying shareholders for 465.8 million shares, representing more than four times the 114.0 million shares available. The full amount of 114.0 million shares will be issued in connection with the open offer. Company says applications for open offer shares under the excess application facility will be scaled back on a pro-rata basis. Expects dealings in the new shares to commence in London on Thursday. Current stock price: 0.30p, down 9.1% on Wednesday in London 12-month change: multiplied from 0.050p on November 12, 2024 Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
